Real estate investment trusts sit at the intersection of income generation and interest-rate sensitivity, making them a focal point for investors navigating today's monetary-policy backdrop. NURE and USRT are both passively managed U.S. REIT ETFs, yet they occupy very different niches within the same asset class. NURE is a thematic fund that isolates REITs with short-term lease structures, while USRT is a broad core fund spanning the full equity REIT market. For investors deciding between concentrated tactical exposure and diversified core positioning, this ETF comparison clarifies the structural trade-offs that drive relative performance. I also checked this using Tickeron’s AI Screener to see how the holdings stack up across key metrics.
NURE tracks the Dow Jones U.S. Select Short-Term REIT Index, a float-adjusted, market-cap-weighted subset of U.S. REITs whose property types generate cash flows from shorter-duration leases. This design deliberately reduces interest-rate sensitivity relative to traditional long-lease REITs. The fund is passively managed and rebalances with a roughly 5% cap per holding, limiting single-name concentration.
The portfolio holds approximately 30 securities concentrated in apartments, self-storage, hotels, and manufactured housing. Top holdings have included HST, RHP, EXR, PSA, SUI, CUBE, ESS, UDR, ELS, and AMH, with the top ten accounting for roughly half of assets. The fund charges a 0.35% expense ratio and is a relatively small product with limited average daily volume, making it a less liquid vehicle than its broad-market peers.
USRT seeks to track the FTSE Nareit Equity REITs 40 Act Capped Index, a broad, market-cap-weighted benchmark of U.S.-listed equity REITs that excludes mortgage, infrastructure, and timber REITs. The fund is passively managed and generally invests at least 80% of assets in index constituents, offering diversified, low-cost core real estate exposure.
The portfolio holds roughly 126 securities spanning specialized, healthcare, retail, residential, industrial, office, and hotel REITs. Top holdings have included WELL, PLD, EQIX, SPG, DLR, PSA, O, VMRK, VTR, and IRM. With a 0.08% expense ratio, billions in assets under management, and substantial daily trading volume, USRT is among the most cost-efficient and liquid ways to own broad U.S. REIT exposure.
Both funds operate within the U.S. REIT sector, whose performance is closely tied to interest-rate expectations, credit conditions, and property-level fundamentals. Rate-sensitive property types — including apartments, hotels, and self-storage that anchor NURE — tend to reprice rents quickly, which can support income during inflationary periods but also increases cyclicality. By contrast, USRT's broader mix includes structural-growth segments such as data centers, towers, and healthcare real estate that are less directly tied to the short end of the yield curve. Sector rotation between growth-oriented and yield-oriented REITs, along with earnings cycles among the largest holdings, has been a recurring driver of relative positioning in recent market cycles.
Over recent weeks and months, the two funds have diverged in ways consistent with their construction. NURE's concentrated short-lease exposure makes it more sensitive to near-term shifts in lodging demand, apartment rent growth, and storage fundamentals, translating into higher volatility and sharper drawdowns historically. USRT, with its diversified and large-cap tilt, has generally offered a smoother return profile and broader participation across healthcare, industrial, and specialized REITs. In fund performance terms, USRT's lower fee drag and deeper liquidity reinforce its appeal as a core holding, while NURE behaves more like a tactical expression of a specific rate and lease-duration view. From what I see, this distinction matters most for investors seeking steady core exposure rather than targeted bets.
When comparing ETFs like NURE and USRT, I often rely on Tickeron’s AI Screener to quickly filter holdings, costs, and liquidity metrics across the sector. It helps surface structural differences efficiently and supports more informed decisions without manual effort. This tool has become a regular part of my workflow for narrowing down similar products in real time.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for USRT crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on USRT as a result. In 68 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for USRT just turned positive on October 09, 2026. Looking at past instances where USRT's MACD turned positive, the stock continued to rise in 39 of 45 cases over the following month. The odds of a continued upward trend are 87%.
USRT moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where USRT advanced for three days, in 261 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 248 of 310 cases where USRT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
The 10-day RSI Indicator for USRT moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 21 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 88%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for USRT moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where USRT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
USRT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category RealEstate